Pricing

Log inSign up

Eidos Therapeutics

22 people · 0 jobs
‌

Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company’s singular mission is to improve and prolong the lives of patients suffering from this disease. Launched in 2016 after years of research supported by Stanfor... Read more

Industries

Biotechnology

Headquarters

San Francisco, United States

Employees

51-200

Links

Org chart

NK
Neil Kumar
Chief Executive Officer
Collapse
US
Uma Sinha
Chief Scientific Officer
Matt Outten
Chief Commercial Officer
SH
Stuart Heminway
Senior Vice President, Regulatory Affairs, BridgeBio Cardiorenal
OV
Olga Vlaskina
Director of Administration and Operations
AS
Ananth Sridhar
Senior Vice President, Corporate Development

Board & advisors

Mamoun Alhamadsheh
Board Member, Co-Founder
Isabella Graef
Board Member, Co-Founder

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

171 followers

Regeneron

144 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

Explore companies